Two more top FDA officials hit the exits as an exodus of senior regulators continues
Today will be the last day on the job for two key FDA officials, marking the latest departures in a recent exodus of senior regulators from the agency.
A spokesperson for the agency confirmed that Curtis Rosebraugh, the director of the Office of Drug Evaluation II, and Donna Griebel, who’s headed the Division of Gastroenterology and Inborn Errors Products, are both retiring April 28. They were both part of the Office of New Drugs, under the control of Janet Woodcock since January, 2017, when John Jenkins left after delaying his departure in an attempt to keep her out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.